Literature DB >> 24332599

Aortic biomechanics by magnetic resonance: early markers of aortic disease in Marfan syndrome regardless of aortic dilatation?

Gisela Teixido-Tura1, Alban Redheuil2, Jose Rodríguez-Palomares3, Laura Gutiérrez3, Violeta Sánchez4, Alberto Forteza5, Joao A C Lima6, David García-Dorado3, Artur Evangelista3.   

Abstract

BACKGROUND: Previous studies demonstrated the usefulness of MRI in the evaluation of aortic biomechanics in Marfan patients with aortic dilatation. However, these parameters have not been well studied in earlier stages of aortic disease. The present work aimed to study aortic biomechanics: aortic distensibility (AD) and pulse wave velocity (PWV), by MRI in Marfan patients without advanced aortic disease.
METHODS: Eighty consecutive Marfan patients were compared with 36 age- and sex-matched controls. MRI images at the level of ascending, descending and abdominal aorta were used to determine AD and PWV.
RESULTS: Marfan patients (27 men; age: 32.0 ± 10.5 years; mean aortic root diameter: 37.2 ± 4.6mm) had lower AD at all levels (ascending 2.6 ± 2.1 vs. 6.2 ± 3.7 mm Hg(-1)·10(-3), p<0.001; descending 3.1 ± 2.0 vs. 8.3 ± 4.2, p<0.001; and abdominal 4.5 ± 2.2 vs. 14.0 ± 5.2, p<0.001), higher aortic arch PWV (8.1 ± 6.5 vs. 4.3 ± 1.8m/s, p<0.01) and ascending-to-abdominal PWV (6.1 ± 3.0 vs. 4.7 ± 1.5m/s, p<0.01) compared with controls. Thirty-five Marfan patients had a non-dilated aortic root (mean aortic root diameter: 34.5 ± 3.8 mm). In multivariable analyses, after adjustment for age, pulse pressure and aortic dimensions, AD remained lower and PWV higher in Marfan patients; even Marfan patients with non-dilated aortic root showed impaired aortic biomechanics compared with controls. Z-score for ascending AD<-3.5 distinguished Marfan patients from controls with 82.5% sensitivity and 86.1% specificity.
CONCLUSIONS: Aortic biomechanics by MRI were abnormal in the entire aorta in Marfan patients. Moreover, Marfan patients without dilated aortic root showed clear impairment of aortic biomechanics, which suggests that they may be used as early markers of aortic involvement in these patients.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Aortic distensibility; Magnetic resonance imaging; Marfan syndrome; Pulse wave velocity

Mesh:

Year:  2013        PMID: 24332599     DOI: 10.1016/j.ijcard.2013.11.044

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  13 in total

Review 1.  Differences in manifestations of Marfan syndrome, Ehlers-Danlos syndrome, and Loeys-Dietz syndrome.

Authors:  Josephina A N Meester; Aline Verstraeten; Dorien Schepers; Maaike Alaerts; Lut Van Laer; Bart L Loeys
Journal:  Ann Cardiothorac Surg       Date:  2017-11

Review 2.  Central artery stiffness and thoracic aortopathy.

Authors:  J D Humphrey; G Tellides
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-11-09       Impact factor: 4.733

3.  Cine-CMR partial voxel segmentation demonstrates increased aortic stiffness among patients with Marfan syndrome.

Authors:  Parmanand Singh; Zaid Almarzooq; Noel C F Codell; Yi Wang; Mary J Roman; Richard B Devereux; Jonathan W Weinsaft
Journal:  J Thorac Dis       Date:  2017-04       Impact factor: 2.895

Review 4.  Potential predictors of severe cardiovascular involvement in Marfan syndrome: the emphasized role of genotype-phenotype correlations in improving risk stratification-a literature review.

Authors:  Zoltán Szabolcs; Kálmán Benke; Roland Stengl; Bence Ágg; Miklós Pólos; Gábor Mátyás; Gábor Szabó; Béla Merkely; Tamás Radovits
Journal:  Orphanet J Rare Dis       Date:  2021-05-31       Impact factor: 4.123

Review 5.  Marfan syndrome.

Authors:  Dianna M Milewicz; Alan C Braverman; Julie De Backer; Shaine A Morris; Catherine Boileau; Irene H Maumenee; Guillaume Jondeau; Arturo Evangelista; Reed E Pyeritz
Journal:  Nat Rev Dis Primers       Date:  2021-09-02       Impact factor: 65.038

6.  Functional and Biochemical Endothelial Profiling In Vivo in a Murine Model of Endothelial Dysfunction; Comparison of Effects of 1-Methylnicotinamide and Angiotensin-converting Enzyme Inhibitor.

Authors:  Anna Bar; Mariola Olkowicz; Urszula Tyrankiewicz; Edyta Kus; Krzysztof Jasinski; Ryszard T Smolenski; Tomasz Skorka; Stefan Chlopicki
Journal:  Front Pharmacol       Date:  2017-04-10       Impact factor: 5.810

7.  Decreased rotational flow and circumferential wall shear stress as early markers of descending aorta dilation in Marfan syndrome: a 4D flow CMR study.

Authors:  A Guala; G Teixido-Tura; L Dux-Santoy; C Granato; A Ruiz-Muñoz; F Valente; L Galian-Gay; L Gutiérrez; T González-Alujas; K M Johnson; O Wieben; A Sao Avilés; A Evangelista; J Rodriguez-Palomares
Journal:  J Cardiovasc Magn Reson       Date:  2019-10-14       Impact factor: 5.364

8.  Inhibition of HIPK2 Alleviates Thoracic Aortic Disease in Mice With Progressively Severe Marfan Syndrome.

Authors:  Cristina I Caescu; Jens Hansen; Brittany Crockett; Wenzhen Xiao; Pauline Arnaud; Bart Spronck; Alan Weinberg; Takeshi Hashimoto; Sae-Il Murtada; Roshan Borkar; James M Gallo; Guillaume Jondeau; Catherine Boileau; Jay D Humphrey; John Cijiang He; Ravi Iyengar; Francesco Ramirez
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-07-29       Impact factor: 10.514

9.  Estimation of aortic pulse wave transit time in cardiovascular magnetic resonance using complex wavelet cross-spectrum analysis.

Authors:  Ioannis Bargiotas; Elie Mousseaux; Wen-Chung Yu; Bharath Ambale Venkatesh; Emilie Bollache; Alain de Cesare; Joao A C Lima; Alban Redheuil; Nadjia Kachenoura
Journal:  J Cardiovasc Magn Reson       Date:  2015-07-30       Impact factor: 5.364

10.  Aortic Function's Adaptation in Response to Exercise-Induced Stress Assessing by 1.5T MRI: A Pilot Study in Healthy Volunteers.

Authors:  Laurence Bal-Theoleyre; Alain Lalande; Frank Kober; Roch Giorgi; Frederic Collart; Philippe Piquet; Gilbert Habib; Jean-François Avierinos; Monique Bernard; Maxime Guye; Alexis Jacquier
Journal:  PLoS One       Date:  2016-06-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.